• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

侵袭性高分化甲状腺癌的管理:美国头颈学会共识声明。AHNS共识声明。

Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement.

作者信息

Shindo Maisie L, Caruana Salvatore M, Kandil Emad, McCaffrey Judith C, Orloff Lisa A, Porterfield John R, Shaha Ashok, Shin Jennifer, Terris David, Randolph Gregory

机构信息

Department of Otolaryngology - Head and Neck Surgery, Oregon Health and Science University, Portland, Oregon.

出版信息

Head Neck. 2014 Oct;36(10):1379-90. doi: 10.1002/hed.23619. Epub 2014 Aug 23.

DOI:10.1002/hed.23619
PMID:24470171
Abstract

BACKGROUND

Invasive differentiated thyroid cancer (DTC) is relatively frequent, yet there is a paucity of specific guidelines devoted to its management. The Endocrine Committee of the American Head and Neck Society (AHNS) convened a panel to provide clinical consensus statements based on review of the literature, synthesized with the expert opinion of the group.

METHODS

An expert panel, selected from membership of the AHNS, constructed the manuscript and recommendations for management of DTC with invasion of recurrent laryngeal nerve, trachea, esophagus, larynx, and major vessels based on current best evidence. A Modified Delphi survey was then constructed by another expert panelist utilizing 9 anchor points, 1 = strongly disagree to 9 = strongly agree. Results of the survey were utilized to determine which statements achieved consensus, near-consensus, or non-consensus.

RESULTS

After endorsement by the AHNS Endocrine Committee and Quality of Care Committee, it received final approval from the AHNS Council.

摘要

背景

侵袭性分化型甲状腺癌(DTC)相对常见,但针对其治疗的具体指南却很匮乏。美国头颈协会(AHNS)内分泌委员会召集了一个专家小组,根据文献综述并结合该小组的专家意见,提供临床共识声明。

方法

一个从AHNS成员中挑选出的专家小组,基于当前最佳证据,撰写了关于侵袭喉返神经、气管、食管、喉和大血管的DTC治疗的手稿及建议。然后,另一位专家小组成员利用9个锚点(1 = 强烈反对至9 = 强烈同意)构建了一项改良德尔菲调查。调查结果用于确定哪些声明达成了共识、接近共识或未达成共识。

结果

在得到AHNS内分泌委员会和医疗质量委员会的认可后,该声明获得了AHNS理事会的最终批准。

相似文献

1
Management of invasive well-differentiated thyroid cancer: an American Head and Neck Society consensus statement. AHNS consensus statement.侵袭性高分化甲状腺癌的管理:美国头颈学会共识声明。AHNS共识声明。
Head Neck. 2014 Oct;36(10):1379-90. doi: 10.1002/hed.23619. Epub 2014 Aug 23.
2
Indications and extent of central neck dissection for papillary thyroid cancer: An American Head and Neck Society Consensus Statement.甲状腺乳头状癌中央区颈清扫术的适应证及范围:美国头颈学会共识声明
Head Neck. 2017 Jul;39(7):1269-1279. doi: 10.1002/hed.24715. Epub 2017 Apr 27.
3
Comprehensive management of recurrent thyroid cancer: An American Head and Neck Society consensus statement: AHNS consensus statement.复发性甲状腺癌的综合管理:美国头颈学会共识声明:AHNS共识声明
Head Neck. 2016 Dec;38(12):1862-1869. doi: 10.1002/hed.24513. Epub 2016 Sep 22.
4
Immediate and partial neural dysfunction after thyroid and parathyroid surgery: Need for recognition, laryngeal exam, and early treatment.甲状腺和甲状旁腺手术后立即出现的部分神经功能障碍:需要识别、进行喉镜检查及早期治疗。
Head Neck. 2020 Dec;42(12):3779-3794. doi: 10.1002/hed.26472. Epub 2020 Sep 21.
5
Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery.美国临床内分泌医师协会(AACE)和美国头颈部学会内分泌外科分会(AHNS-ES)关于小儿良性和恶性甲状腺手术的共识声明。
Head Neck. 2021 Apr;43(4):1027-1042. doi: 10.1002/hed.26586. Epub 2021 Jan 1.
6
Consensus Statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS) on Pediatric Benign and Malignant Thyroid Surgery.美国临床内分泌医师协会(AACE)和美国头颈外科协会内分泌外科分会(AHNS)关于儿科良性和恶性甲状腺手术的共识声明。
Endocr Pract. 2021 Mar;27(3):174-184. doi: 10.1016/j.eprac.2020.12.001. Epub 2020 Dec 10.
7
American Head and Neck Society Endocrine Section clinical consensus statement: North American quality statements and evidence-based multidisciplinary workflow algorithms for the evaluation and management of thyroid nodules.美国头颈学会内分泌分会临床共识声明:北美质量声明和循证多学科工作流程算法,用于评估和管理甲状腺结节。
Head Neck. 2019 Apr;41(4):843-856. doi: 10.1002/hed.25526. Epub 2018 Dec 18.
8
Locally invasive papillary thyroid carcinoma: 1940-1990.局部侵袭性乳头状甲状腺癌:1940 - 1990年
Head Neck. 1994 Mar-Apr;16(2):165-72. doi: 10.1002/hed.2880160211.
9
[Surgical treatment of differentiated thyroid carcinoma with laryngeal or tracheal invasion].[伴有喉或气管侵犯的分化型甲状腺癌的外科治疗]
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2014 Dec;28(24):1934-7.
10
Prognosis and management of invasive well-differentiated thyroid cancer.侵袭性高分化甲状腺癌的预后与管理
Otolaryngol Clin North Am. 2010 Apr;43(2):301-28, viii. doi: 10.1016/j.otc.2010.02.002.

引用本文的文献

1
Neoadjuvant lenvatinib in a patient with invasive poorly differentiated thyroid cancer.一名侵袭性低分化甲状腺癌患者的新辅助乐伐替尼治疗
Ecancermedicalscience. 2025 Apr 25;19:1902. doi: 10.3332/ecancer.2025.1902. eCollection 2025.
2
Impact of gross extrathyroidal extension to the recurrent laryngeal nerve alone on survival in papillary thyroid carcinoma.仅甲状腺外大体侵犯至喉返神经对甲状腺乳头状癌患者生存的影响。
Br J Surg. 2025 Mar 28;112(4). doi: 10.1093/bjs/znaf030.
3
The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.
日本内分泌外科学会2024年修订的甲状腺肿瘤管理临床指南。
Endocr J. 2025 May 7;72(5):545-635. doi: 10.1507/endocrj.EJ24-0644. Epub 2025 Mar 8.
4
Influence factors and survival outcomes of different invasion sites in locally advanced thyroid cancer and new site-based risk stratification system.局部晚期甲状腺癌不同侵犯部位的影响因素及生存结局与基于新部位的风险分层系统
Endocrine. 2025 May;88(2):501-510. doi: 10.1007/s12020-025-04165-3. Epub 2025 Feb 11.
5
The role of external-beam radiotherapy for differentiated thyroid cancer.外照射放疗在分化型甲状腺癌中的作用。
Jpn J Clin Oncol. 2025 Feb 4;55(2):95-99. doi: 10.1093/jjco/hyae158.
6
Neoadjuvant Treatment in Locally Advanced Thyroid Carcinoma.局部晚期甲状腺癌的新辅助治疗
J Clin Med. 2024 Sep 27;13(19):5769. doi: 10.3390/jcm13195769.
7
Application of modified spiral tracheoplasty in thyroid carcinoma with trachea invasion: a retrospective analysis of 15 cases.改良螺旋状气管成形术在甲状腺癌气管受侵中的应用:15 例回顾性分析。
World J Surg Oncol. 2024 Oct 3;22(1):264. doi: 10.1186/s12957-024-03541-z.
8
European Society of Endocrine Surgeons (ESES) consensus statement on advanced thyroid cancer: definitions and management.欧洲内分泌外科学会(ESES)关于晚期甲状腺癌的共识声明:定义与管理
Br J Surg. 2024 Aug 2;111(8). doi: 10.1093/bjs/znae199.
9
Treatment of Unresectable , -Mutated Differentiated Papillary Thyroid Cancer With Dabrafenib and Trametinib.用达拉非尼和曲美替尼治疗不可切除的、BRAF突变的分化型甲状腺癌
JCEM Case Rep. 2024 Jul 30;2(8):luae112. doi: 10.1210/jcemcr/luae112. eCollection 2024 Aug.
10
Effect and Safety of Apatinib as Neoadjuvant Therapy in Locally Advanced Differentiated Thyroid Cancer: A Phase 2 Trial.阿帕替尼作为局部晚期分化型甲状腺癌新辅助治疗的疗效与安全性:一项2期试验
J Endocr Soc. 2024 Jul 12;8(9):bvae132. doi: 10.1210/jendso/bvae132. eCollection 2024 Jul 26.